These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 35904817)

  • 1. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
    Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
    Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
    Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
    Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of SDHC promotes metastasis by reprogramming fatty acid metabolism in colorectal cancer.
    Ding Z; Wei Y; Dai J; Pan C; Yang L; Li Q; Zhang Y; Yan Q; Wu C; Li A; Lan Z; Liu S; Wang X
    J Transl Med; 2024 Jun; 22(1):544. PubMed ID: 38844980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis.
    Zhang W; Hou J; Wang X; Jiang R; Yin Y; Ji J; Deng L; Huang X; Wang K; Sun B
    Oncotarget; 2015 Apr; 6(11):9420-33. PubMed ID: 25826083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
    Wang C; Chen Z; Yi Y; Ding Y; Xu F; Kang H; Lin K; Shu X; Zhong Z; Zhang Z; Liu J; Xu Z; Liu L; He X; Chang Y; Zhao Q
    Oncogene; 2024 Jan; 43(5):328-340. PubMed ID: 38040804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
    Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
    Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein Regulates Lipid Metabolism via Estrogen Receptor β and Its Downstream Signal Akt/mTOR in HepG2 Cells.
    Qin H; Song Z; Shaukat H; Zheng W
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
    Wu D; Yang Y; Hou Y; Zhao Z; Liang N; Yuan P; Yang T; Xing J; Li J
    Cancer Commun (Lond); 2022 Jan; 42(1):37-55. PubMed ID: 34981667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
    Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F
    Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
    Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
    Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt Serine/Threonine Kinase 1 Regulates de Novo Fatty Acid Synthesis through the Mammalian Target of Rapamycin/Sterol Regulatory Element Binding Protein 1 Axis in Dairy Goat Mammary Epithelial Cells.
    Zhang T; Huang J; Yi Y; Zhang X; Loor JJ; Cao Y; Shi H; Luo J
    J Agric Food Chem; 2018 Feb; 66(5):1197-1205. PubMed ID: 29323924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
    Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic avian reovirus σA-modulated fatty acid metabolism through the PSMB6/Akt/SREBP1/acetyl-CoA carboxylase pathway to increase energy production for virus replication.
    Hsu CY; Chen YH; Huang WR; Huang JW; Chen IC; Chang YK; Wang CY; Chang CD; Liao TL; Nielsen BL; Liu HJ
    Vet Microbiol; 2022 Oct; 273():109545. PubMed ID: 35998542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
    Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ménage à trois of autophagy, lipid droplets and liver disease.
    Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
    Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
    Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.